A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)
NCT02698852 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000
Last updated 2024-04-25
Summary
PIONEER-II OPC trial is a prospective, multicenter, single-arm registry trial. 1000 subjects from approximately 40 interventional cardiology centers will be enrolled to evaluate the target lesion failure(TLF) as the primary endpoint at 1 year. And all the subjects will be followed up to 5 years to attain the data of the secondary endpoints.
Conditions
Interventions
- DEVICE
-
BuMA Supreme
Stent platform: cobalt-chromium alloy
Sponsors & Collaborators
-
Sino Medical Sciences Technology Inc.
lead INDUSTRY
Principal Investigators
-
Junbo Ge, M.D. · Shanghai Zhongshan Hospital
-
Shubin Qiao, M.D. · Chinese Academy of Medical Sciences, Fuwai Hospital
-
Yundai Chen, M.D. · Chinese PLA General Hospital
-
Shaoping Nie, M.D. · Beijing Anzhen Hospital
-
Yawei Xu, M.D. · Shanghai 10th People's Hospital
-
Xiangqing Kong, M.D. · Jiangsu Proving Hospital
-
Lang Li, M.D. · First Affiliated Hospital of Guangxi Medical University
-
Xiangqian Shen, M.D. · Central South University
-
Hui Li, M.D. · Daqing oilfield general hospital
-
Linghong Shen, M.D. · Shanghai Chest Hospital
-
Xi Su, M.D. · Wuhan Asia Heart Hospital
-
Jiyan Chen, M.D. · Guangdong Provincial People's Hospital
-
Genshang Ma, M.D. · Zhongda Hospital
-
Xiaoshu Cheng, M.D. · Second Affiliated Hospital of Nanchang University
-
Guosheng Fu, M.D. · Run Run Shaw Hospital
-
Zesheng Xu, M.D. · Cangzhou Central Hospital
-
Bin Li, M.D. · Hainan General Hospital
-
Jianan Wang, M.D. · The Second Affiliated Hospital of Zhejiang University School of Medical College
-
Haichu Yu, M.D. · The Affiliated Hospital of Qingdao University
-
Guotai Shen, M.D. · Jiangxi Provincial People's Hopital
-
Xiandong Li, M.D. · Shengjing Hospital
-
Xianxian Zhao, M.D. · Changhai Hospital
-
Tingbo Jiang, M.D. · The First Affiliated Hospital of Soochow University
-
Mingzhe Li, M.D. · Xuzhou Central Hospital
-
Zheng Zhang, M.D. · LanZhou University
-
Bei Shi, M.D. · Zunyi Medical College
-
Jinyu Huang, M.D. · Affiliated Hangzhou First People's Hospital ,Zhengzhou University School of Medicine
-
Honghua Ye, M.D. · Hua Mei Hospital, University of Chinese Academy of Sciences(Ningbo No.2 Hospital)
-
Guohai Su, M.D. · Jinan Central Hospital
-
Hanjun Pei, M.D. · The First Affiliated Hospital of BaoTou Medical College
-
Shaobin Jia, M.D. · General Hospital of Ningxia Medical University
-
Chun Liang, M.D. · Shanghai Changzheng Hospital
-
Ronghai Man, M.D. · Chifeng Municipal Hospital
-
Jinchuan Yan, M.D. · Affiliated Hospital of Jiangsu University
-
Xuchen Zhou, M.D. · The First Affiliated Hospital of Dalian Medical University
-
Zhenyu Yang, M.D. · Wuxi People's Hospital
-
Yuehui Yin, M.D. · The Second Affiliated Hospital of Chongqing Medical University
-
Chunlai Zeng, M.D. · The Central Hospital of Lishui City
-
Kejun Huang, M.D. · Henan Provincial Chest Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-12-31
- Primary Completion
- 2019-05-31
- Completion
- 2025-12-31
Countries
- China
Study Locations
More Related Trials
-
China Made Sirolimus Eluting Stent for Intermediate Lesion
NCT01375296 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Prospective, Randomized, Multicenter Trial to Assess PROMUS™ Element™ Stent
NCT01285999 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of NOYA Sirolimus-Eluting Stent to Treat Coronary Artery Disease
NCT02216058 ·Status: UNKNOWN ·Phase: NA
-
Study Safety and Performance of the Biomime Stent in Patients With Single, De Novo, Non-Complex Coronary Lesions
NCT01507519 ·Status: COMPLETED ·Phase: NA
-
Comparison of BuMA eG Based BioDegradable Polymer Stent With EXCEL Biodegradable Polymer Sirolimus-eluting Stent in "Real-World" Practice
NCT02017275 ·Status: COMPLETED ·Phase: PHASE4
-
Bare -Metal Stents and Drug -Eluting Stents in the Treatment of Patients With Vertebral Artery Ostium Stenosis
NCT02197559 ·Status: COMPLETED
-
Prospective Assessment of Efficacy and Safety of Drug Eluting Stents
NCT02313038 ·Status: COMPLETED
-
EXCEL-II Stent Vesus EXCEL Stent to Treat the Patients With de Novo Coronary Artery Lesions.
NCT02057978 ·Status: COMPLETED
-
IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease
NCT04849325 ·Status: UNKNOWN ·Phase: NA
-
Drug Eluting Stents Versus Bare Metal Stents for Treatment of Symptomatic Extracranial Vertebral Artery Stenosis
NCT03201432 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries
NCT00896337 ·Status: COMPLETED ·Phase: PHASE3
-
Optical Coherence TomOgraphy Assessment of the Drug-Eluting Stent
NCT01012583 ·Status: UNKNOWN
-
RESOLUTE ONYX China RCT Study
NCT03466151 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
DESTINY TRIAL (Inspiron x Biomatrix)
NCT01856088 ·Status: COMPLETED ·Phase: PHASE4
-
The Safety and Efficacy of Biolimus in the Treatment of Patients With in Stent Restenosis
NCT04733443 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions
NCT00825773 ·Status: UNKNOWN ·Phase: PHASE4
-
Test Efficacy of Biodegradable and Permanent Limus-Eluting Stents
NCT01068106 ·Status: UNKNOWN ·Phase: PHASE4
-
BIOTRONIK Orsiro Pre-Marketing Registration
NCT02870985 ·Status: COMPLETED ·Phase: NA
-
The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions
NCT05033964 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis
NCT00691314 ·Status: COMPLETED ·Phase: NA
-
PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)
NCT01510327 ·Status: COMPLETED ·Phase: PHASE3
-
Firehawk™ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s)
NCT03040934 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Nano+ Polymer-free Sirolimus-Eluting Stent: A Optical Coherent Tomography Study
NCT01925027 ·Status: UNKNOWN ·Phase: PHASE4
-
EXCEL-II DES to Treat the Patients With de Novo Coronary Artery Lesions. (CREDIT-III)
NCT02027870 ·Status: COMPLETED
-
Drug Eluting Stents In The Critically Ischemic Lower Leg 2
NCT01442636 ·Status: COMPLETED ·Phase: PHASE2/PHASE3